DalsnaFinance

Invictus Pharmacy and Mullan Pharmaceutical Inc. Announce Strategic Partnership to Expand Patient Access to FDA-Approved Ganirelix Acetate Injection Through Invictus Pharmacy

Markets PR Newswire By PR Newswire 07 Jul 2026 19:09 1 min read
Invictus Pharmacy and Mullan Pharmaceutical Inc. Announce Strategic Partnership to Expand Patient Access to FDA-Approved Ganirelix Acetate Injection Through Invictus Pharmacy

Partnership Leverages Invictus Pharmacy's Direct-to-Patient Nationwide Licensed Platform to Deliver FDA-Approved Ganirelix Acetate Injection Across All 50 States NEW YORK, July 7, 2026 /PRNewswire/ -- Invictus Pharmacy, a vertically integrated, nationwide licensed pharmacy platform...

Partnership Leverages Invictus Pharmacy's Direct-to-Patient Nationwide Licensed Platform to Deliver FDA-Approved Ganirelix Acetate Injection Across All 50 States NEW YORK, July 7, 2026 /PRNewswire/ -- Invictus Pharmacy, a vertically integrated, nationwide licensed pharmacy platform...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.